sarah walsh

sarah walsh

oncology caregiver

Country

united states

City

houston

Industry

biotechnology

Skill

oncology, gastroenterology, immunology, pharmaceutical industry, biotechnology, pharmaceutical sales, managed care, hematology, psychiatry, sales, medical devices, healthcare, urology, hospitals, management, cancer, lifesciences

Experience

verkin properties

project developer and manager

verkin properties

2006-1 - 2007-1 · 1 yr 1 mo
caris life sciences

sales director, oncology target now and carisomes

caris life sciences

2011-2 - 2012-7 · 1 yr 6 mos
eli lilly and company

institutional psychiatric sales representative

eli lilly and company

2002-8 - 2006-1 · 3 yrs 6 mos
allstate

licensed sales representative

allstate

2000-6 - 2002-8 · 2 yrs 3 mos
biodesix, inc.

oncology clinical diagnostics manager

biodesix, inc.

2013-10 - Present · 13 yrs
oncology/glioblastoma

oncology caregiver

oncology/glioblastoma

2015-2 - Present · 11 yrs 8 mos

Coordinating care for my terminally ill husband

galena biopharma, inc.

oncology territory business manager

galena biopharma, inc.

2014-6 - Present · 12 yrs 4 mos
prometheus laboratories inc., a nestlé health science company

gastroenterology technical sales specialist

prometheus laboratories inc., a nestlé health science company

2007-1 - 2011-2 · 4 yrs 2 mos
dendreon

oncology immunology sales specialist

dendreon

2012-7 - Present · 14 yrs 3 mos

Dendreon Corporation is a biotechnology company targeting cancer and transforming lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon's first autologous cellular immunotherapy product, PROVENGE(R) (sipuleucel-T), was approved by the FDA in April 2010 for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer. Dendreon also is developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer. The Company is headquartered in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com/

Education

texas a&m university

texas a&m university

biomedical science

1998-1 - 2002-1 · 4 yrs 1 mo

Activities and Societies: Alpha Phi Omega

sarah walsh's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.